Clinical Research and Epidemiology in Diabetes and Endocrinology

描述（由申请人提供）：约翰霍普金斯大学糖尿病和内分泌学培训项目的临床研究和流行病学正在申请完成9.5年的资助后的第二次竞争性更新。2002年，Christopher Saudek博士和Frederick Brancati博士在约翰霍普金斯大学建立了一个培训项目，致力于糖尿病和内分泌学的临床和流行病学研究。十年后，它仍然是美国唯一的同类产品。到目前为止，我们已经成功地培养了16名年轻学者（6名博士生和10名博士后），他们已经发表了61篇同行评审的科学论文，并在全国各地担任研究职位。在上一个供资周期，我们培训了3名代表性不足的少数族裔（2名关于多样性补充）和12名妇女。我们的计划包括3个博士前和3个博士后职位，所有这些职位都是在过去5年中填补的。Saudek博士英年早逝后，Brancati博士与流行病学交叉培训的内分泌学家Sherita Golden博士一起担任培训项目的领导。这一新的领导班子在执行和咨询委员会的支持下，提出了第三个供资周期，其具体目标如下：（1）招募一批不同的内分泌学一流青年受训人员（博士后）和流行病学（准博士）从一个国家人才库吸引到约翰霍普金斯;（2）招收他们参加约翰霍普金斯布隆伯格公共卫生学院严格的、有论文的流行病学和临床研究硕士和博士课程;（3）让他们接触到韦尔奇预防、流行病学和临床研究中心强大的团队导向、多学科的临床和流行病学研究文化，该中心是约翰霍普金斯大学临床研究培训的首要教育基地;（4）指导每一位受训者到一位经验丰富的、由国家卫生研究院资助的导师那里，导师将负责成功完成一个重要的论文项目。为了实现这些目标，我们的计划汇集了来自成人和儿科内分泌学和普通内科（医学院），流行病学系（公共卫生学院），韦尔奇预防，流行病学和临床研究中心以及护理学院的教师和学员。16名导师将担任初级教师，并因其专业知识，卓越的指导和积极的NIH资助而被选中。增加了新的导师，他们具有临床试验、健康差异、行为科学和基于社区的干预措施方面的专业知识。如果我们的建议是成功的，那么约翰霍普金斯将继续发挥重要的国家作用，在培训下一代的病人和人口为导向的研究人员在糖尿病和内分泌学。

DESCRIPTION (provided by applicant): The Clinical Research and Epidemiology in Diabetes and Endocrinology Training Program at Johns Hopkins University is applying for its second competitive renewal after completing 9.5 years of funding. In 2002 Drs. Christopher Saudek and Frederick Brancati established a training program at Johns Hopkins devoted to clinical and epidemiologic research in diabetes and endocrinology. Ten years later, it remains the only one of its kind in the US. Thus far, we have successfully trained 16 young scholars (6 pre-docs and 10 post docs) who have produced 61 peer-reviewed scientific papers and who hold research positions across the country. During the last funding cycle, we trained 3 under-represented minorities (2 on diversity supplements) and 12 women. Our program includes 3 pre-doctoral and 3 post-doctoral slots, all of which were filled during each of the past 5 years. Following Dr. Saudek's untimely death, Dr. Brancati assumed leadership of the training program, together with Dr. Sherita Golden, an endocrinologist cross-trained in epidemiology. This new leadership team, supported by an Executive and Advisory Committee, proposes a third cycle of funding with the following specific aims: (1) to recruit a diverse group of top-notch young trainees in endocrinology (post-docs) and epidemiology (pre-docs) from a national pool of talent attracted to Johns Hopkins; (2) to enroll them in rigorous, thesis-bearing Masters' and PhD programs in Epidemiology and Clinical Investigation in the Johns Hopkins Bloomberg School of Public Health; (3) to expose them to a strong team-oriented, multi-disciplinary clinical and epidemiologic research culture in the Welch Center for Prevention, Epidemiology, and Clinical Research-the premier educational home for clinical research training at Johns Hopkins; (4) to guide each trainee to an experienced, NIH- funded mentor who will take responsibility for the successful completion of a significant thesis project. To accomplish these goals, our program brings together faculty and trainees from the Divisions of Adult and Pediatric Endocrinology and General Internal Medicine (School of Medicine), the Department of Epidemiology (School of Public Health), the Welch Center for Prevention, Epidemiology, and Clinical Research, and the School of Nursing. Sixteen mentors will serve as primary faculty and were selected for their expertise, excellence in mentoring, and active NIH funding. New mentors have been added with expertise in clinical trials, health disparities, behavioral science, and community-based interventions. If our proposal is successful, then Johns Hopkins will continue to play a major national role in training the next generation of patient- and population-oriented researchers in diabetes and endocrinology.